Results 161 to 170 of about 620,324 (385)

Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

European Journal of Heart Failure, EarlyView.
The beneficial effects of finerenone in patients with heart failure (HF) and mildly reduced or preserved ejection fraction were consistent, regardless of a history of chronic obstructive pulmonary disease (COPD) status. BMI, body mass index; LVEF, left ventricular ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.
Jawad H. Butt, Pardeep S. Jhund, Alasdair D. Henderson, Brian L. Claggett, Akshay S. Desai, Carolyn S.P. Lam, Katharina Mueller, Markus F. Scheerer, Prabhakar Viswanathan, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J.V. McMurray   +16 more
wiley   +1 more source

Mechanism of generation of body surface electrocardiographic P-waves in normal, middle, and lower sinus rhythms. [PDF]

, 1981
William J. Eifler, Emilio Macchi, Henk J. Ritsema van Eck, B. Milan Horáček, P M Rautaharju   +4 more
openalex   +1 more source

Heart failure in patients with a systemic right ventricle: A multicentre study with long‐term follow‐up

European Journal of Heart Failure, EarlyView.
Risk of heart failure hospitalization in patients with a systemic right ventricle. AF, atrial fibrillation; AtrSO, atrial switch operation; ccTGA, congenitally corrected transposition of the great arteries; D‐TGA, dextro‐transposition of the great arteries; ECG, electrocardiogram; HF, heart failure; HR, hazard ratio; NYHA, New York Heart Association ...
Mohammad Mostafa Ansari Ramandi, Werner Budts, Jolien W. Roos‐Hesselink, Willem A. Helbing, Anastasia D. Egorova, Berto J. Bouma, Anthonie Duijnhouwer, Roland van Kimmenade, Gertjan T. Sieswerda, Thelma C. Konings, Lodewijk J. Wagenaar, Joey F.A. Ubachs, Rolf M.F. Berger, Elke S. Hoendermis, Adriaan A. Voors, Joost P. van Melle   +15 more
wiley   +1 more source

Effects of lidocaine and procainamide on normal and abnormal intraventricular electrograms during sinus rhythm. [PDF]

, 1988
Claus Schmitt, Alan H. Kadish, Francis E. Marchlinski, John M. Miller, Alfred E. Buxton, Mark E. Josephson   +5 more
openalex   +1 more source

The interaction between atrial fibrillation and mitral regurgitation: Insights from the CABANA randomized clinical trial

European Journal of Heart Failure, EarlyView.
Effects of baseline mitral regurgitation in the CABANA trial: randomization to catheter ablation versus drug therapy in patients with atrial fibrillation. AF, atrial fibrillation; CCS, Canadian Cardiovascular Society; MR, mitral regurgitation; NYHA, New York Heart Association; OR, odds ratio.
Sebastiaan Dhont, Philippe B. Bertrand, Jonas Erzeel, Sébastien Deferm, Laurent Pison, Pieter M. Vandervoort, Wilfried Mullens, W.H. Wilson Tang, Pieter Martens   +8 more
wiley   +1 more source

Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE‐TR registry

European Journal of Heart Failure, EarlyView.
Aetiological phenotypes of secondary tricuspid regurgitation. AF, atrial fibrillation; HFpE, heart failure with preserved ejection fraction; CARE‐TR, Consecutive pAtients with seveRE Tricuspid Regurgitation evaluated in Heart Failure and Valve Clinics; HF, heart failure; HFmrEF, heart failure with mildly reduced ejection fraction; HFrEF, heart failure ...
Laura Lupi, Elena Antonioli, Angelica Praderio, Alessandro Villaschi, Elisa Soranzo, Nicola Saccani, Kamil Stankowski, Daniele Cocianni, Beniamino Pagliaro, Valeria Magni, Marco Loffi, Daniela Tomasoni, Matteo Pagnesi, Antonio Mangieri, Davide Stolfo, Gianfranco Sinagra, Marianna Adamo, Marco Metra   +17 more
wiley   +1 more source

Noninvasive recovery of epicardial potentials in a realistic heart-torso geometry. Normal sinus rhythm. [PDF]

, 1990
Barbara J. Messinger‐Rapport, Yoram Rudy   +1 more
openalex   +1 more source

Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial

European Heart Journal, 2018
M. Rienstra, A. H. Hobbelt, M. Alings, J. Tijssen, M. D. Smit, J. Brügemann, B. Geelhoed, R. Tieleman, H. Hillege, R. Tukkie, D. V. van Veldhuisen, H. Crijns, I. V. Van Gelder   +12 more
semanticscholar   +1 more source

Characterization of arrhythmia‐induced cardiomyopathy using magnetic resonance imaging in patients with persistent atrial fibrillation and left ventricular systolic dysfunction – insights from DECAAF II

European Journal of Heart Failure, EarlyView.
Arrhythmia‐induced cardiomyopathy (AIC) in left ventricular systolic dysfunction with atrial fibrillation (AF). HFrEF, heart failure with reduced ejection fraction; LVEF, left ventricular ejection fraction; MRI, magnetic resonance imaging. Abstract Aims Atrial fibrillation (AF) ablation in heart failure reduces mortality and hospitalizations and ...
Ala Assaf, Han Feng, Mayana Bsoul, Ghassan Bidaoui, Hadi Younes, Christian Massad, Mario Mekhael, Charbel Noujaim, Omar Kreidieh, Swati Rao, Amitabh Pandey, Philipp Sommer, Christian Mahnkopf, Nassir Marrouche, Christian Sohns   +14 more
wiley   +1 more source

Present and future of antiarrhythmic therapy for atrial fibrillation: A review

Consilium Medicum
Despite the emergence and active development of interventional methods for the treatment of arrhythmias, to date, the use of antiarrhythmic drugs to recover and maintain sinus rhythm is the most significant and in demand in patients with paroxysmal and ...
Aida I. Tarzimanova
doaj   +1 more source